Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00801619 · ClinicalTrials.gov registry record
Bilicurves: Using Information Technology to Improve the Management of Neonatal Hyperbilirubinemia
A clinical trial of Neonatal Hyperbilirubinemia, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 273
- Enrollment target
- 1
- Study location
NCT00801619 is a study of Neonatal Hyperbilirubinemia that has completed, run by Massachusetts General Hospital. The registered enrollment target is 273 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00801619, a study of Neonatal Hyperbilirubinemia, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 273 participants
- Enrollment target
- 1
- Study location
Study Summary
We will use information technology to integrate the 2004 American Academy of Pediatrics guidelines for management of neonatal hyperbilirubinemia with laboratory reporting of newborn bilirubin test results to improve physician adherence to the guidelines and quality of care.
Conditions Studied
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 273 participants |
| Start Date | 2008-11 |
| Est. Completion | 2011-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00801619
The ClinicalTrials.gov registry entry for NCT00801619 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 273 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neonatal Hyperbilirubinemia appearing as the primary indexed condition, and to 0 interventions.
NCT00801619 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00801619 about?
NCT00801619 is a clinical study titled "Bilicurves: Using Information Technology to Improve the Management of Neonatal Hyperbilirubinemia". We will use information technology to integrate the 2004 American Academy of Pediatrics guidelines for management of neonatal hyperbilirubinemia with laboratory reporting of newborn bilirubin test results to improve physician adherence to the guidelines and quality of care.
What is the current status of trial NCT00801619?
This trial is currently completed. The enrollment target is 273 participants. The study started on 2008-11. Estimated completion is 2011-12.
What conditions does trial NCT00801619 study?
This clinical trial studies the following conditions: Neonatal Hyperbilirubinemia.
Who is sponsoring clinical trial NCT00801619?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00801619 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.